SuperworthOric Pharmaceuticals market cap ORIC
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $1.4B
- Highest close in our data
- $1.5B
- Aug 2026
Oric Pharmaceuticals is worth $1.4B at the close on Oct 23, 2026, at $13.17 a share.
That is up 7% over the last year and up 137% over five years.
Its highest close in our data was $1.5B in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.4B | $776.4M | $1.5B | +70% |
| 2025 | $803.5M | $336.2M | $1.3B | +38% |
| 2024 | $582.2M | $459.3M | $1B | +16% |
| 2023 | $501.9M | $168.6M | $514.4M | +115% |
| 2022 | $233.1M | $97.4M | $564.3M | −60% |
| 2021 | $578.9M | $555.7M | $1.1B | −45% |
| 2020 | $1B | $591.9M | $1.2B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Oric Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| ORICOric Pharmaceuticals | $1.4B |
| PCRXPacira BioSciences | $1.5B |
| ANABAnaptysbio | $1.5B |
| OMEROmeros | $1.2B |
| PAHCPhibro Animal Health | $1.6B |
| ANIPANI Pharmaceuticals | $1.7B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| HRMYHarmony Biosciences | $2.1B |
| ABUSArbutus Biopharma | $831M |
| PBHPrestige Consumer Healthcare | $2.3B |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Oric Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.